结核病指数病例的密切接触者队列中的最小免疫细胞子集差异
Sudhasini Panda1, Catherine Cheng1, Naomi Hillery2
1Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Tuberculosis (Edinburgh, Scotland)
|November 18, 2025
概括
结核病 (TB) 接触者的免疫反应在QuantiFERON-TB Gold (QFT) 测试模式中显示出极小的差异. 血液测试难以检测早期的免疫变化,突显了区分结核病感染阶段的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 结核病研究 结核病研究
背景情况:
- 了解结核病 (TB) 感染中的免疫反应变异至关重要.
- 在不同结核病感染状态的个体中,免疫变化的范围仍然不清楚.
研究的目的:
- 根据序列QuantiFERON-TB Gold (QFT) 测试结果,调查结核病患者的亲密接触者之间的免疫反应差异.
- 评估ex vivo免疫表型的实用性,以区分QFT亚组和活性结核病.
主要方法:
- 在结核病患者接触者中进行系列QFT测试 (0,3,6,12个月).
- 在体外对CD4,CD8,NKT细胞,记忆T细胞和激活T细胞 (HLA-DR+CD38+) 进行免疫表型鉴定.
- 在QFT子组和活跃结核病 (ATB) 患者之间比较免疫特征.
主要成果:
- 在不同的QFT亚组中观察到免疫细胞频率和激活配置文件的最小差异.
- 活体免疫表型学未能区分QFT亚组,这表明血液分析对微妙变化的概况有局限性.
- 与非患病状态相比,活跃结核病患者表现出明显的免疫变化,这些变化在治疗后得到缓解.
结论:
- 基于血液的免疫分析缺乏灵敏度来解决结核病接触者中的基于QFT的子组.
- 目前的ex vivo方法可以有效地区分活性结核病,但不能通过QFT动态表明早期免疫过渡.
- 需要进一步的研究来确定早期结核病感染阶段的敏感生物标志物.
更多相关视频
10:43Polarization of M1 and M2 Human Monocyte-Derived Cells and Analysis with Flow Cytometry upon Mycobacterium tuberculosis Infection
Published on: September 18, 2020
32.0K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.9K
相关概念视频
Pulmonary Tuberculosis I
811
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
811
Pulmonary Tuberculosis III
901
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
901
Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
Pulmonary Tuberculosis II
1.3K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.3K
Pulmonary Tuberculosis V
530
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
530
